Recombinant Human Lymphotoxin-alpha(LTA) (Active)
Recombinant Human Lymphotoxin-alpha(LTA) (Active)

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

Recombinant Human Lymphotoxin-alpha(LTA) (Active)
Cat:
GS13205
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Type:
Protein
Alias:
Expressed Host:
Mammalian cell
Species:
Homo sapiens (Human)
Price:
  • Product details
Product Name
Recombinant Human Lymphotoxin-alpha(LTA) (Active)
Cat
GS13205
Expression Region
Uniorot ID:P01374(35-205aa)
Alias
Expressed Host
Mammalian cell
Species
Homo sapiens (Human)
Tag
N-terminal 6xHis-tagged
Purity
Greater than 95% as determined by SDS-PAGE.
Endotoxin
Less than 1.0 EU/ug as determined by LAL method.
Buffer
Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0
Biological activity
①Measured by its binding ability in a functional ELISA. Immobilized LTA at 5 μg/ml can bind human TNFRSF1B (CSB-MP023978HU2), the EC50 is 1.632-2.699 ng/ml.②Measured by its binding ability in a functional ELISA. Immobilized LTA at 5 μg/ml can bind human TNFR1(CSB-MP023977HU1), the EC50 of human LTA protein is 4.409-6.797 ng/ml.
Storage
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Type
Protein
Purposes
For research use only